Z-0614-2013 Class II Terminated
FDA device recall Z-0614-2013 was initiated by Roche Molecular Systems, Inc. on Oct 11, 2012 and is designated Class II. Reason for recall: Certain COBAS AmpliPrep instruments using AMPILINK software v.3.3.4 had the sample clot detection flagging feature disabled during quality control release resulting in samples that may not be flagged… The recall status is terminated (terminated Sep 11, 2013). Affected quantity: 7 units.
Recall details
- Product Type
- Devices
- Report Date
- Jan 2, 2013
- Initiation Date
- Oct 11, 2012
- Termination Date
- Sep 11, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7 units
Product description
COBAS AmpliPrep Instrument (CAP) with AMPLILINK (AL) Software v.3.3.5 Automated sample processing instrument used with CAP/CA and CAP/CTM. Roche Molecular Systems, Inc. 1080 US Highway 202 South Branchburg, NJ 08876 USA Made in Switzerland
Reason for recall
Certain COBAS AmpliPrep instruments using AMPILINK software v.3.3.4 had the sample clot detection flagging feature disabled during quality control release resulting in samples that may not be flagged as having clots.
Distribution pattern
Distributed in the states of GA, CA, NC, and MN.
Code information
CAP 394436 to 394663
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0614-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026